SB Investment Advisers (UK) Ltd Sells $17M in Shares of Vir Biotechnology
In a May 2026 SEC filing, SB Investment Advisers (UK) Ltd reported selling nearly 2.17 million shares of Vir Biotechnology for an estimated $17.28 million during the first quarter. Despite this sale, Vir's stock has risen by almost 93% over the past year and currently trades at a price of $8.79.
Tickers: $VIR
Topics: investment adviser activity SEC filing Vir Biotechnology